The table below shows Gain Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
$55.18K
$140.11K
$164.99K
$28.88K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$10.21M
$10.79M
$11.52M
$8.38M
$7.16M
$2.26M
SG&A
$8.50M
GANX annual revenue (10-K history)
Gain Therapeutics, Inc. reported annual revenue of $55.18K for fiscal year 2023. That is down 60.6% from $140.11K in fiscal 2022. Figures come from the company's audited annual reports as filed with the SEC.